Full Length Research Paper
References
| American Society of Health-System Pharmacists (January (2012). "Azathioprine, Azathioprine Sodium". AHFS Drug Information 2012. American Society of Health-System Pharmacists. | ||||
|
Clark R, Strasser J, McCabe S, Robbins K, Jardieu P (1993). Insulin-like growth factor-1 stimulation of lymphopoiesis. J. Clin. Investig. 92(2):540-8. Crossref |
||||
|
Evans WE (2004). Pharmacogenetics of thiopurine S-methyltransferase and thiopurine therapy. Ther. Drug Monit. 26(2):186–91. Crossref |
||||
|
Guh JH, Ko FN, Jong TT, Teng CM (1995). Antiplatelet effect of gingerol isolated from Zingiber officinale. J. Pharm. Pharmacol. 47(4): 329-332. Crossref |
||||
|
Hirose J, Kouro T, Igarashi H, Yokota T, Sakaguchi N, Kincade PW (2002). A developing picture of lymphopoiesis in bone marrow. Immunol. Rev. 189:28-40. Crossref |
||||
|
Ichii M, Oritani K, Yokota T, Nishida M, Takahashi I, Shirogane T, Ezoe S, Saitoh N, Tanigawa R, Kincade PW, Kanakura Y (2008). Regulation of human B lymphopoiesis by the transforming growth factor-beta superfamily in a newly established coculture system using human mesenchymal stem cells as a supportive microenvironment. Exp. Hematol. 36(5):587-97. Crossref |
||||
| International Agency for Research on Cancer (IARC) (1987). Azathioprine"Azathioprine". Summaries & and Evaluations (World Health OrganizationWorld Health Organization). Suppl.7:119. | ||||
|
Kumar A, Leonard MC, Cleveland RP (1989). Development of a leukocytopenic baby guinea pig model with azathioprine and cyclophosphamide. Compar. Immunol. Microbiol. Infect. Dis. 12(4):91-4. Crossref |
||||
|
Maltzman JS, Koretzky GA (2003). Azathioprine: Old drug, new actions. J. Clin. Investig. 111(8):1122–1124. Crossref |
||||
|
Mowrey DB, Clayson DE (1982). Motion sickness, ginger and psychophysics. Lancet 319(8273):655-657. Crossref |
||||
| Mustafa T, Srivastava KC, Jensen KB (1993). Pharmacology of ginger, Zingiber officinale. J. Drug Dev. 6(1): 25-39. | ||||
|
Nuyttens JJ, Harper J, Jenrette JM, Turrisi AT (2005). Outcome of radiation therapy for renal transplant rejection refractory to chemical immunosuppression. Radiother. Oncol. 74(1):17–19. Crossref |
||||
|
Patel AA, Swerlick RA, McCall CO (2006). Azathioprine in dermatology: The past, the present, and the future. J. Am. Acad. Dermatol. 55(3):369–389. Crossref |
||||
|
Remuzzi G, Lesti M, Gotti E, Ganeva M, Dimitrov BD, Ene-Iordache B, Gherardi G, Donati D, Salvadori M, Sandrini S, Valente U, Segoloni G, Mourad G, Federico S, Rigotti P, Sparacino V, Bosmans JL, Perico N, Ruggenenti P (2004). Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial. Lancet 364(9433):503–12. Crossref |
||||
|
Surh YJ (1999). Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances. Mutat. Res. 428(1):305-327. Crossref |
||||
|
Tanabe M, Chen KI, Kano Y (1993). Cholesterol biosynthesis inhibitory component from Zingiber officinale Roscoe. Chem. Pharm. Bull. 41(4):710-713. Crossref |
||||
|
Topic B, Tani E, Tsiakitzis K, Kourounakis PN, Dere E, Hasenohrl, RU, Hacker R, Mattern CM, Huston JP (2002). Enhanced maze perfor-mance and reduced oxidative stress by combined extracts of Zingiber officinale and Gingko biloba in the aged rat. Neurobiol. Aging 23(1):135-143. Crossref |
||||
| Tyler VE, Robbers JE (1999). Tyler's herbs of choice: the therapeutic use of phytomedicals. 2nd ed. New York: The Haworth Herbal Press. | ||||
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
